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Neutral Red UptakeAbstract The aim of our study was to examine the irritation potential of new eye drops containing
2% choline salicylate (CS) as an active pharmaceutical ingredient (API) and various polymers
increasing eye drop viscosity (hydroxyethylcellulose, hydroxypropyl methylcellulose, methylcellu-
lose, polyvinyl alcohol, polyvinylpyrrolidone). The standard method for assessing the potential
of irritating substances has been the Draize rabbit eye test. However the European Centre for Val-
idation of Alternative Methods and the Coordinating Committee for Validation of Alternative
Methods recommend, short time exposure (STE) in vitro tests as an alternative method for assessing
eye irritation. The eye irritation potential was determined using cytotoxicity test methods for rabbit
corneal cell line (SIRC) after 5 min exposure. The viability of cells was determined using two cyto-
toxicity assays: MTT and Neutral Red Uptake. According to the irritation rankings for the short
time exposure test, all tested eye drops are classiﬁed as non-irritating (cell viability >70%).
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
From a number of pharmaceutical dosage forms applied
topically to the eye, the most common and widely used remaincontinuously eye drops (Lu, 2010). Their preparation requires
special consideration with regard to sterility, preservation, iso-
tonicity, buffering, viscosity and ocular bioavailability. In addi-
tion to physiological factors affecting ocular bioavailability,
other factors such as physicochemical characteristics of the
active pharmaceutical ingredient (API) and excipients are
important. The evaluation of irritation potential of API as well
as of the excipients is essential to secure the patient safety. For
several years the method of choice to determine eye irritation
potential was the Draize rabbit eye test (Wilhelmus, 2001).
However, ethical considerations and the limited value of animal
models including lack of reproducibility and overestimation of
408 K. Wroblewska et al.human responses became the impetus for the development of
alternative in vitro tests (Vinardell and Mitjans, 2008). As
the ocular surface is a very complex system (corneal and
conjunctival epithelial cells, the underlying stroma, and
associated cells), it is difﬁcult to develop the tests with a
physiological and mechanistic base that are capable of eliminat-
ing the need for animals. Generally the in vitro model has been
designed for only one tissue but in the eye there are more
tissues. This is useful in obtaining more detailed data on the
mechanical irritation of the eye. However, experiments on
animals have to be replaced with several in vitro studies, such
as: red blood cell test, isolated cornea and eye tests, as well as
culture cell tests, which have different targets (da Nobrega
et al., 2012; Donahue et al., 2011; Gerner et al., 2005;
McNamee et al., 2009).
The European Centre for Validation of Alternative Meth-
ods (ECVAM) and the Interagency Coordinating Committee
for Validation of Alternative Methods (ICCVAM) supervise
the development of alternative methods. Both organizations
recommend short time exposure (STE) in vitro test using a rab-
bit corneal cell line (SIRC) as an alternative method for assess-
ing eye irritation (EVCAM, 2007; Li et al., 2009; Prinsen, 2006;
Sakaguchi et al., 2011; Takahashi et al., 2008).
The aim of our study was to apply two in vitro tests (MTT
and NRU) for assessing the irritation potential of new eye
drops containing choline salicylate as API and various poly-
mers improving eye drops viscosity (Repetto et al., 2008).
2. Materials and methods
2.1. Chemicals
Choline salicylate (CS) was kindly obtained from ICN Polfa
Rzeszo´w S.A. The following polymers: hydroxyethylcellulose
(HEC), hydroxypropyl methylcellulose (HPMC), methylcellu-
lose (MC) and polyvinylpyrrolidone (PVP) were supplied from
Sigma–Aldrich. Polyvinyl alcohol (PVA) and disodium ethyl-
enediaminetetraacetate (Na2EDTA) were purchased from
POCH SA. Sodium chloride from Pharma Cosmetics, sodium
bicarbonate from PPH Galfarm, and sodium metabisulﬁte
from Fluka were used. Ultrapure water was produced by Mil-
lipore Simplicity UV system.
The Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
without phenol red, fetal bovine serum (FBS), 0.25%
trypsin EDTA solution, phosphate buffered saline (PBS),Table 1 Composition of examined eye drops with choline salicylat
Active ingredient/excipient Content in
A
Choline salicylate (CS)
Hydroxyethylcellulose (HEC) 0.25
Hydroxypropyl methylcellulose (HPMC)
Methylcellulose (MC)
Polyvinyl alcohol (PVA)
Polyvinylpyrrolidone (PVP)
Sodium chloride +
Sodium bicarbonate +
Disodium ethylenediaminetetraacetate (Na2EDTA)
Sodium metabisulﬁte
Water ultrapuremethylthiazolyldiphenyl-tetrazolium bromide (MTT), neutral
red were obtained from Sigma Aldrich (St. Louis, Mi, USA).
Penicillin–streptomycin and L-glutamine solution were
obtained from Gibco Invitrogen Corp. (Grand Island, NY,
USA). Dimethyl sulfoxide was obtained from POCh, S.A.
(Gliwice, Poland).
2.2. Eye drops
Three series of eye drops without polymers, containing increas-
ing quantities of choline salicylate (1.0% CS, 2.0% CS, and
3.0% CS) were prepared. Appropriate amounts of choline
salicylate were dissolved in water containing suitable quantities
of tonicity adjusting agent (sodium chloride). After mixing, the
drops were ﬁltered through ﬁlter Schott G3, poured into infu-
sion bottles of 100 ml and sterilized in the Exacta M.O.COM
autoclave at the temperature of 122 ± 2 C for 20 min. under
steam pressure 101.4 kPa. After 12 h of sterilization physico-
chemical parameters of drops were tested.
In the next stage six types of eye drops with increased vis-
cosity (A-F) containing 2.0% choline salicylate were prepared.
Received eye drops differed in type and concentration of the
polymer used, and comprised respectively: 0.25% hydroxyeth-
ylcellulose (A), 0.5% hydroxyethylcellulose (B), 0.5%
hydroxypropyl methylcellulose (C), 0.25% methylcellulose
(D), 2.0% polyvinyl alcohol (E) or 5% polyvinylpyrrolidone
(F). Their compositions are presented in Table 1. As in the
case of eye drops mentioned above, eye drops of increased
viscosity (A-F) were poured into infusion bottles and sterilized
in the Exacta M.O.COM autoclave at the temperature of
122 ± 2 C for 20 min. under steam pressure 101.4 kPa. After
12 h of sterilization physicochemical parameters of eye drops
were tested.
2.3. Cell culture
The cytotoxicity study was determined for rabbit corneal cell
line (SIRC) obtained from European Collection of Cell Cul-
tures (Salisbury, UK). The cell line was cultured in DMEM
medium, without phenol red supplemented with 10% (v/v)
FBS, 1% penicillin–streptomycin and 1% L-glutamine. The
cells were cultured at temperature 37 C, in a humidiﬁed atmo-
sphere containing 5% CO2. The cytotoxicity assays for three
eye drops formulations (1% CS, 2% CS and 3% CS) and
new eye drops (A-F), with 2% choline salicylate and differente.
eye drops (g)
B C D E F
2.00
0.50
0.50
0.25
2.00
5.00
+ + + + +
+ + + + +
+
+
ad 100
Table 2 Physicochemical properties of eye drops with various
concentrations of choline salicylate without polymers increased
viscosity.
Parameter Eye drops (mean ± SD, n= 3)
1% CS 2% CS 3% CS
pH (mean ± SD) 7.4 ± 0.01 7.6 ± 0.02 7.5 ± 0.02
Tonicity (mOsm/L)
(mean ± SD)
289 ± 0.5 295 ± 0.6 305 ± 0.6
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trol cells were exposed to solution containing all ingredients
without the active compound. The 0.9% solution of sodium
chloride was used as a control for cells treated only with drops
containing choline salicylate. The relative viability after adding
the test sample and exposing for 5 min was the targets of the
STE test.
2.4. The short time exposure (STE) tests
2.4.1. MTT assay
The MTT assay was employed to assess rabbit corneal cell via-
bility after treatment with examined eye drops. Cells were
seeded in 96-well plates at a density 2 · 104 cells per well and
incubated overnight at 37 C before experiment. Subsequently,
tested solutions were given to each well except the well with
control solution, for 5 min. After incubation the cells were
rinsed twice with PBS. Next 170 ll of reaction solution con-
taining methylthiazolyldiphenyl-tetrazolium bromide solution
(0.5 mg/mL) in culture medium was added to each well. The
plates were incubated for 3 h at 37 C, and then centrifuged
at 1300 rpm for 3 min. The formazan crystals were extracted
with 200 ll DMSO and plates were shaken for 10 min. The
absorbance was measured at 570 nm with plate reader (Biotek
Instruments, Elx-800). Cell viability was calculated as a per-
centage of the control.
2.4.2. Neutral Red Uptake (NRU)
The SIRC cells were seeded at a density 2 · 104 cells per well in
96-well plates and incubated overnight under cell culture con-
dition. After incubation, the cells were exposed to tested solu-
tions for 5 min. Subsequently, plates were washed twice with
PBS and the 100 ll of neutral red (5 mg/mL in distilled water)
in medium was added into each well. The cells were incubated
with neutral red for 2 h at 37 C. The dye was extracted with a
mixture of 1% acetic acid : 50% ethanol, and the absorbance
was measured using a spectrophotometer at 540 nm with
plate reader (Biotek Instruments, Elx-800). The results were
calculated as a percentage of the NRU by untreated cells
(Repetto et al., 2008).
2.5. Statistical analysis in cytotoxicity tests
The results are presented as the mean ± SD from three inde-
pendent experiments repeated six times. The values were calcu-
lated using GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA. Data were
compared for statistical signiﬁcance by the Tukey’s Multiple
Comparison Test, a probability value (P) of less than 0.05
was considered signiﬁcant.
3. Results and discussion
The aim of the conducted research was to characterize as well
as to check the potential irritant effect of the new eye drops
with choline salicylate.
Analyzing the qualitative composition of the developed eye
drops (Table 1) it can be concluded that all the excipients used
have been monographed in the current pharmacopeias
which guarantees their quality required by regulatory agencies(ORMPMDBP, 2011). However, taking into consideration
that there is no data available on the behavior of choline salic-
ylate in contact with the cornea cells, it seemed to be necessary
to check its potential irritant effect. Due to the existing guid-
ance on the possible limitations of the studies involving exper-
imental animals, short-term exposure tests were used in the
assessment of ocular irritation. Among the several possibilities,
in our study two STE tests with different endpoints were cho-
sen. The ﬁrst was MTT assay which is a colorimetric assay
based on the ability of viable cells to reduce a soluble yellow
salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), to blue formazan crystals. MTT reduction is
associated not only with mitochondria, but also with the cyto-
plasm and with non-mitochondrial membranes including the
endosome/lysosome compartment and the plasma membrane
(Berridge et al., 2005). The second test applied was the Neutral
Red Uptake assay (NRU) which is based on the ability of via-
ble cells to incorporate and bind the supravital dye neutral red
in the lysosomes (Repetto et al., 2008). Therefore, the results of
both assays may give a more complete picture of the mecha-
nisms of the corneal cell damage.
Considering the fact that the choline salicylate is cur-
rently not used in any ophthalmic drug dosage form it was
purposeful to examine its impact on corneal cells. Therefore,
eye irritation assessment was carried out for drops containing
only choline salicylate, isotonized with sodium chloride solu-
tion (without the polymers). For this purpose, three series of
drops containing 1%, 2% and 3% of choline salicylate were
prepared and characterized. As it is apparent from the data
presented in Table 2 the analyzed drops did not differ
signiﬁcantly as regards pH values (7.4–7.6), and osmotic
pressure (289–305 mOsm/L). The values of both the aforemen-
tioned parameters resembled the physiological values of lacri-
mal ﬂuid.
Analyzing the results of short time exposure (STE) tests
performed for SIRC cell line (Fig. 1), it can be concluded that
increase of SC concentration in eye drops does not affect cor-
neal cell viability. The relative cell viability values ranged from
101.77% to 93.71% and showed no signiﬁcant differences
between the control and tested solutions. The CV > 70% indi-
cates, that all tested drops may be considered as non-irritant
(NI) according to Sakaguchi et al. classiﬁcation (Sakaguchi
et al., 2011).
The next step of our study referred to six series of developed
eye drops containing 2% of CS, and characterized by different
viscosity (Table 1). As thickeners were chosen ﬁve synthetic
and semisynthetic polymers commonly used in pharmaceutical
manufacturing and extemporaneous compounding (Rowe
et al., 2012).
Figure 1 The viability of SIRC cell line after exposition to drops
containing increasing concentration of choline salicylate, using
MTT and NRU assays. Data represented as mean ± standard
deviation. Statistical signiﬁcance between groups was assessed by
Tukey’s Multiple Comparison Test (p< 0.05). Abbreviations:
C – control, CS – choline salicylate.
410 K. Wroblewska et al.Due to a great diversity of eye structures and the require-
ments concerning the properties of eye medicines, the critical
attributes affecting patient comfort as well as stability and
safety of use have to be considered in the preparation step.Table 4 The results of short time exposure (STE) tests performed
Sample Cell viability (%)
MTT
Mean SD
Control 100.00 19.71
1% CS 101.77 17.90
2% CS 93.79 13.97
3% CS 93.71 22.66
Control 100.00 7.21
Drops A0.25%HEC 95.93 11.14
Control 100.00 9.85
Drops B0.5%HEC 103.75 8.02
Control 100.00 8.46
Drops C0.5%HPMC 93.94 8.13
Control 100.00 14.03
Drops D0.25%MC 97.20 12.97
Control 100.00 9.14
Drops E2%PVA 97.29 13.90
Control 100.00 9.98
Drops F5%PVP 81.82 12.25
Abbreviations: CS – choline salicylate, PVA – polyvinyl alcohol, PVP – pol
– hydroxyethylcellulose, MC – methylcellulose, NI – non-irritant, CV –
a Eye irritation potential classiﬁcation STE. The result CV > 70% is c
Table 3 Physicochemical properties of examined eye drops with ch
Parameter Eye drops (mean ± SD, n= 3)
A B C
pH 7.79 ± 0.011 7.50 ± 0.073 7.45 ±
Viscosity (mPa s) 5.08 ± 0.055 11.42 ± 0.095 4.21 ±
Tonicity (mOsm/L) 299.3 ± 11.6 324.7 ± 5.7 292.7 ±
Polymer HEC HPMC
Abbreviations: PVA – polyvinyl alcohol, PVP – polyvinylpyrrolidone, HP
MC – methylcelluloseBesides sterility, pH, viscosity, and isotonicity are of great
importance.
Having analyzed the data presented in Table 3 it might be
noted that pH (5.65–7.79) of all formulations is in a good
agreement with the pH range of most commercial products
(5–7), and except of drops E with 2% PVA, pH of remaining
drops was adjusted to within the normal tear ﬂuid pH of 7.14–
7.80 (Al-Achi et al., 2013).
The values of drops osmolality did not differ more than by
10%, and fell in the range from 288.7 mOsm/L (drops E) to
324.7 mOsm/L (drops B). Taking into account, that normal
osmolality of tears ranges from 290 to 310 mOsm/L, it can
be assumed that the all developed eye drops should be well
tolerated.
A possible approach to extend API residence time in the eye,
thereby prolonging drug absorption, is to incorporate the vis-
cosity increasing agents into the vehicle. Analyzing viscosity
of particular eye drops series containing polymers it is possible
to observe that its value does not exceed the admissible value of
20 mPa s (ORMPMDBP, 2011) and remains within the range of
2.44 mPa s (drops F) to 11.42 mPa s (drops B).
It can be concluded that the viscosity of the tested eye
drops, as well as their pH and osmotic pressure values, meetsfor SIRC cell line.
STE classiﬁcationa
NRU
Mean SD
100.00 13.63
93.72 13.63 NI
95.44 17.06 NI
90.97 16.66 NI
100.00 9.43
103.81 14.00 NI
100.00 15.14
97.50 11.91 NI
100.00 10.16
91.88 11.27 NI
100.00 15.88
101.57 9.15 NI
100.00 13.73
76.43 13.47 NI
100.00 13.42
102.61 9.28 NI
yvinylpyrrolidone, HPMC – hydroxypropyl methylcellulose, HEC
cell viability
lassiﬁed as non-irritant (Sakaguchi et al., 2011).
oline salicylate.
D E F
0.010 7.68 ± 0.066 5.65 ± 0.028 7.21 ± 0.108
0.066 5.90 ± 0.079 4.14 ± 0.111 2.44 ± 0.049
17.5 292.0 ± 11.5 288.7 ± 9.5 319.7 ± 6.7
MC PVA PVP
MC – hydroxypropyl methylcellulose, HEC – hydroxyethylcellulose,
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form.
In the last step of our study the irritancy potential of devel-
oped formulations was assessed by in vitro STE assays. The cell
viability (CV) as a critical attribute, was determined using the
MTT assay and additionally was extended with NRU assay.
Analyzing the results of two in vitro STE tests, after 5 min. of
exposition to particular series of eyes drops with increased vis-
cosity (Table 4) it can be seen that all series (A-F) of new eye
drops both in the MTT and NRU assay exhibited corneal cell
viability greater than 70%. It means that all examined formula-
tions could be classiﬁed as a non-irritating, according to Sakag-
uchi et al. classiﬁcation (Sakaguchi et al., 2011).
Statistically signiﬁcant differences in cell viability between
control and tested solutions were observed for eye drops F of
5% PVP in the MTT assay (CV = 81.82 ± 12.25%), and for
eye drops E of 2% PVA in NRU assay (CV = 76.43 ±
13.47%) (Figs. 2 and 3).
In case of eye drops of 5% PVP, smaller corneal cell
viability may result from their hypertonicity (319.7 mOsm/L),
and from the addition of adjuvants used in this formulationFigure 2 The viability of SIRC cell line using MTT assay. Data
represented as mean ± standard deviation. Statistical signiﬁcance
(*) between groups was assessed by Tukey’s Multiple Comparison
Test (p< 0.05). Abbreviations: C – control, CS – choline salicy-
late, A-F – examined eye drops, PVA – polyvinyl alcohol, PVP –
polyvinylpyrrolidone, HPMC – hydroxypropyl methylcellulose,
HEC – hydroxyethylcellulose, MC – methylcellulose.
Figure 3 The results from NRU assay. Data represented as
mean ± standard deviation. Statistical signiﬁcance (**) between
groups was assessed by Tukey’s Multiple Comparison Test
(p< 0.05). Abbreviations: C – control, CS – choline salicylate,
A-F – examined eye drops, PVA – polyvinyl alcohol, PVP –
polyvinylpyrrolidone, HPMC – hydroxypropyl methylcellulose,
HEC – hydroxyethylcellulose, MC – methylcellulose.– sodium metabisulﬁte and Na2EDTA, which exhibit antioxi-
dant activity and may themselves act as irritants. For eye drop-
s of 2% PVA CV was 81.82%. This does not indicate
a damaging effect on the corneal cells, but may be related
to their relatively low pH (5.62) which is in the ranges accep-
ted for eye drops but it is about 25% lower than the physiolog-
ical pH of tear ﬂuid. Patients applying such eye drops may
feel discomfort of burning and tearing.
4. Conclusions
Basing on the obtained results it can be concluded that choline
salicylate in tested formulations will not exert irritant effect
after administration of eye drops into the conjunctival sac.
Higher, 3% choline salicylate concentration in the eye drops
does not increase the irritation of the cornea cells, which is
conﬁrmed by no statistically signiﬁcant differences between
control and tested eye drop formulation for both the concen-
tration of 1% and 3% CS.
High CV values obtained for eye drop formulations, which
includes semisynthetic polymers to increase the viscosity, sug-
gest that cellulose derivatives (HEC, HPMC, MC) will be bet-
ter tolerated by the patient upon administration to the eye,
that those with PVP and PVA.
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